Baird Financial Group, Inc. Moderna, Inc. Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 2,016 shares of MRNA stock, worth $132,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,016

Previous 2,066 2.42%

Holding current value

$132,552

Previous $220,000 8.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $5,060 - $8,330	-50 Reduced 2.42%	2,016 $239,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $387,238 - $523,635	-4,536 Reduced 68.71%	2,066 $220,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $130,470 - $196,015	-1,877 Reduced 22.14%	6,602 $656,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $147,796 - $194,093	-1,533 Reduced 15.31%	8,479 $875,000
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $17,775 - $24,079	150 Added 1.52%	10,012 $1.22 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $387,444 - $562,689	-2,856 Reduced 22.46%	9,862 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $509,235 - $837,498	4,313 Added 58.29%	11,712 $1.39 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $248,315 - $374,370	2,120 Added 40.16%	7,399 $1.06 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $140,244 - $260,670	-1,109 Reduced 17.36%	5,279 $909,000
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $568,163 - $927,171	-2,516 Reduced 28.26%	6,388 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $292,464 - $638,531	-1,318 Reduced 12.89%	8,904 $3.43 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $42,610 - $77,073	328 Added 3.32%	10,222 $2.4 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $838,829 - $1.43 Million	7,683 Added 347.49%	9,894 $1.3 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $145,351 - $375,560	2,211 New	2,211 $231,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Moderna, Inc. Transaction History